About Reflection Biotechnologies Limited
Reflection Biotechnologies LimitedReflection Biotechnologies (ReflectionBio®) is a patient-driven biotechnology company that focuses on developing gene therapy and other breakthrough treatments for rare diseases. Rare disease patients shoulder the inevitable odds of genetic mutations for mankind but are often neglected by the society. Rare disease research and orphan drug development are grossly under-supported by public funding and research resources. ReflectionBio® is one of the first biotech companies in the world that is driven directly by rare disease patients.
